GW Pharmaceuticals, a Jazz Pharmaceuticals Company Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by GW Pharmaceuticals, a Jazz Pharmaceuticals Company and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 1161 GW Pharmaceuticals, a Jazz Pharmaceuticals Company employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that GW Pharmaceuticals, a Jazz Pharmaceuticals Company has purchased the following applications: Tableau for Analytics and BI in 2019, Liquid Web Cloud Servers for Application Hosting and Computing Services in 2018, New Relic APM for Application Performance Management in 2020 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems GW Pharmaceuticals, a Jazz Pharmaceuticals Company is running and its propensity to invest more and deepen its relationship with Tableau Software , Liquid Web , Amazon Web Services (AWS) or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing GW Pharmaceuticals, a Jazz Pharmaceuticals Company revenues, which have grown to $527.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for GW Pharmaceuticals, a Jazz Pharmaceuticals Company intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.